Capromorelin oral solution (ENTYCE®) increases food consumption and body weight when administered for 4 consecutive days to healthy adult Beagle dogs in a randomized, masked, placebo controlled study

BACKGROUND: Dogs can suffer from inappetence caused by a variety of medical conditions. This may present as anorexia (complete loss of appetite), hyporexia (decreased appetite) or dysrexia (change in food preferences). A drug with a new mechanism of action, capromorelin, has potential to stimulate a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zollers, Bill, Rhodes, Linda, Heinen, Ernst
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217407/
https://www.ncbi.nlm.nih.gov/pubmed/28056951
http://dx.doi.org/10.1186/s12917-016-0925-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217407/
https://www.ncbi.nlm.nih.gov/pubmed/28056951
http://dx.doi.org/10.1186/s12917-016-0925-z

Ejemplares similares